Background. We report health-related QoL (HRQoL) from GRACE (Gender, Race, And Clinical Experience) study by sex and race over 48 weeks. Methods. 429 treatment-experienced adults (HIV-1 RNA≥1000 copies/mL) received darunavir/ritonavir 600/100 mg twice daily plus an appropriate background regimen. QoL was measured by the Functional Assessment of HIV Infection (FAHI) questionnaire. Results. 67% women and 77% men, including 67.4% black, 76.0% Hispanic, and 73.8% white patients, completed the trial. Baseline total FAHI scores were similar between sexes and races. Total FAHI of the entire population improved by Week 4 (P
CITATION STYLE
Feinberg, J., Saag, M., Squires, K., Currier, J., Ryan, R., Coate, B., & Mrus, J. (2011). Health-related quality of life in the gender, race, and clinical experience trial. AIDS Research and Treatment, 2011. https://doi.org/10.1155/2011/349165
Mendeley helps you to discover research relevant for your work.